Mark Behrman
Analyst · Wells Fargo. Please proceed with you question
Thanks, John. Please turn to Page 10 of the presentation. It provides a consolidated summary statement of our operations for the first quarter of 2017 as compared to 2016. In reviewing our continuing operations, total net sales and gross profit increased for the quarter primarily related to increased production and sales volumes at each one of our facilities which were partially offset by a decrease in average selling prices of our agricultural products. Gross profit improved almost $18 million versus the first quarter of 2016. However, the first quarter of 2016 includes a one time consulting fee expense of $12 million making the true improvement in gross profit approximately $6 million despite additional depreciation expense in the first quarter of 2017 of $6.5 million. In addition to the increase in sales that I just discussed, gross profit increased from improved production that gave us better absorption of fixed cost at all our facilities, lower overall planned fixed cost and lower overall feedstock cost. SG&A expenses decreased by $0.4 million as we continue to focus on cost reductions. However, Q1, 2017 includes about $1 million of additional legal and group insurance expense regarding various outstanding claims. Interest expense for the quarter increased approximately $10 million over Q1, 2016. As I outlined last quarter, the increase reflects the recognition of interest expense associated with debt used to fund the expansion of our El Dorado facility that we've been capitalizing until the new ammonia plant became operational mid-year 2016. At which time, we began recognizing the interest on our income statement. Lastly, adjusted EBITDA was $20 million for the quarter, an $11.7 million improvement versus Q1, 2016 adjusted EBITDA of $8.3 million. Please refer to our reconciliation of non-GAAP measure beginning on slide 17 for further information on non-cash and one time cost during the period. In order to give further clarity on our results for the quarter, page 11 bridges our consolidated adjusted EBITDA for Q1, 2016 to Q1, 2017. As I mentioned earlier, lower selling prices of our products was a big drag on EBITDA as they had a negative impact of almost $13 million as compared to Q1, 2016. However, improved sales volumes of products for the quarter provided an additional approximately $18 million of EBITDA. The sales volume increase was driven by better on-stream rates acquired in Cherokee versus Q1, 2016, improved sales of HDAN as we continue to broaden our distribution of that product, increased ammonia sales as the new ammonia plant in El Dorado was producing during the quarter and was not yet in operation in Q1, 2016 and increased sales of our acid product. Lastly, as we've discussed previously, a significant benefit of the new ammonia plant at our El Dorado facility is producing our own ammonia versus previously purchasing it. During the quarter, we picked up approximately $6.5 million in EBITDA versus the first quarter of 2016 by producing our own ammonia. The right hand column of this page reflects normalized EBITDA which assumes that product selling prices were the same in both the first quarter of 2017 and the first quarter of 2016. While we realize that product selling prices move with general market conditions, this analysis provides a view of the operational improvement activities that we've undertaken and the inherent earnings power of our assets. The year-over-year EBITDA improvement for those operational improvements was approximately $24.4 million showing significantly improved operations. Looking forward to the second quarter, given our strong order book for fertilizer products, improved Ag selling prices over prices we received in the first quarter of 2017, the continuation of the strong operating performance of our plants that John previously discussed, and our continued focus on expense control, we expect improved EBITDA versus our first quarter of 2017. Page 12 outlined our capital structure as of Q1, 2017. We ended the quarter with $45 million in cash. Additionally, our ABL facility was undrawn and had approximately $45 million of availability at quarter end giving us total liquidity of approximately $90 million. As a reminder, our ABL availability varies based on accounts receivable and inventory levels. Total outstanding debt at the end of the quarter was approximately $424 million excluding the unamortized discount and issuance cost associated with our debt. We also had outstanding preferred stock of approximately$167 million including approximately $28 million in accrued and unpaid dividends. As I previously stated for 2017, we currently expect to continue to accrue the dividends in our preferred stock as we do not need 2 to 1 fixed charge coverage ratio needed to make restricted payments. However, assuming current operating rates continue and market fundamentals continue to improve, we would use excess cash to reduce leverage either through repayment of debt or the payment of accrued dividends. Lastly, I've previously discussed the sales of non core assets. We are in the latter stages of successfully divesting several of these assets and anticipate that the process will be complete by the end of Q2, 2017. We expect to generate net proceeds, net of any debt on these assets of between $15 million to $20 million. Moving to Page 13, we outlined our free cash flow. Cash from operations provided approximately $8 million for the quarter. That includes an approximate $7.3 million use of working capital from an increase in accounts receivables as our sales continue to grow. Additionally, cash flow from operations includes the semi-annual interest payment on our senior secured notes. That will occur every first and third quarter of each year. Capital expenditures incurred and paid during Q1, 2017 were approximately $8 million, with another $6 million of capital expenditures incurred in previous periods and paid in Q1, 2017. We continue to expect capital expenditures of $30 million to $35 million for the full year of 2017 as we continue to focus on enhancing the safety and reliability of all of our plants. Net cash used for financing primarily reflects regularly scheduled debt payments in commercial and insurance premium financing. We expect this to decrease over the year with the sale of certain non core assets and the repayment of the related debt. Lastly as I mentioned last quarter, for the full year we expect EBITDA to more than cover the high end of our forecasted ranges of $35 million in CapEx and $35 million in interest expense and we anticipate positive free cash flow for the year. Now I'll turn it back over to Dan to wrap up.